↓ Skip to main content

Cochrane Database of Systematic Reviews

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

Overview of attention for article published in Cochrane database of systematic reviews, March 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
4 news outlets
twitter
1 tweeter
patent
3 patents
wikipedia
13 Wikipedia pages

Citations

dimensions_citation
542 Dimensions

Readers on

mendeley
592 Mendeley
Title
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Published in
Cochrane database of systematic reviews, March 2012
DOI 10.1002/14651858.cd001447.pub3
Pubmed ID
Authors

Robert G Miller, J D Mitchell, Dan H Moore

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 592 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Korea, Republic of 2 <1%
Colombia 1 <1%
Australia 1 <1%
United Kingdom 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 585 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 115 19%
Student > Master 91 15%
Student > Ph. D. Student 87 15%
Researcher 58 10%
Student > Doctoral Student 33 6%
Other 84 14%
Unknown 124 21%
Readers by discipline Count As %
Medicine and Dentistry 150 25%
Agricultural and Biological Sciences 77 13%
Neuroscience 72 12%
Biochemistry, Genetics and Molecular Biology 45 8%
Nursing and Health Professions 24 4%
Other 79 13%
Unknown 145 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 41. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 May 2022.
All research outputs
#809,110
of 21,986,946 outputs
Outputs from Cochrane database of systematic reviews
#1,786
of 12,161 outputs
Outputs of similar age
#8,552
of 208,311 outputs
Outputs of similar age from Cochrane database of systematic reviews
#30
of 213 outputs
Altmetric has tracked 21,986,946 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,161 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.8. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 208,311 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 213 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.